RecruitingNCT06837181

Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)


Sponsor

Jaeb Center for Health Research

Enrollment

200 participants

Start Date

Sep 18, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

This multicenter cross-sectional study will include a diverse population of adolescents and adults with CF. The overall Aim is to describe prevalence of diabetes microvascular complications and macrovascular surrogates in people with established CFRD.


Eligibility

Min Age: 12 Years

Inclusion Criteria6

  • Written informed consent (and assent when applicable) obtained from participant or participant's legally authorized representative
  • For Adults: Must be able to consent on one own's behalf (i.e., cannot lack cognitive capacity to consent due to the required patient-reported outcomes)
  • Be willing and able to adhere to the study protocol requirements
  • Age ≥ 12 years at time of enrollment
  • CF diagnosis based on two CF causing mutations and/or positive sweat test according to CFF diagnostic criteria
  • CFRD diagnosis ≥ 5 years at time of enrollment

Exclusion Criteria10

  • History of any illness or condition that, in the opinion of the investigator might confound the results of the study or pose an additional risk to the subject
  • History of transplant
  • Pregnancy reported by participant at time of consent or at any point during active study participation
  • Erratic, accelerated or mechanically controlled irregular heart rhythms including arrhythmias
  • Carotid or aortic valve stenosis
  • Peripheral artery disease or leg artery disease
  • Generalized constriction or localized spasm of muscular conduit arteries such as seen immediately after hypothermic cardiopulmonary bypass surgery or accompanying Raynaud's phenomena or intense cold.
  • Possible exclusions based on investigator medical provider assessment (additional precautions may be followed to allow inclusion):
  • Pressure reading should not be conducted on a limb where there is intravenous access, arterio-venous shunt, or where circulation is compromised.
  • Pressure reading should not be conducted on the side of the body that a mastectomy was done.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERobservational study

This is an observational study.


Locations(18)

University of Alabama at Birmingham

Birmingham, Alabama, United States

Keck Medical Center of USC

Los Angeles, California, United States

Stanford University

Palo Alto, California, United States

University of California San Diego

San Diego, California, United States

University of Colorado Denver

Aurora, Colorado, United States

University of Miami

Miami, Florida, United States

Emory University School of Medicine

Atlanta, Georgia, United States

University of Iowa

Iowa City, Iowa, United States

Tulane University

New Orleans, Louisiana, United States

Massachusetts

Boston, Massachusetts, United States

University of Minnesota

Minneapolis, Minnesota, United States

University of New Mexico

Albuquerque, New Mexico, United States

Columbia University Cystic Fibrosis Program

New York, New York, United States

Atrium Health Wake Forest Baptist (Wake Forest Baptist)

Winston-Salem, North Carolina, United States

The Children's Hospital of Philadelphia

Philadelphia, Pennsylvania, United States

Medical University of South Carolina

Charlestone, South Carolina, United States

Baylor College of Medicine

Houston, Texas, United States

The University of Texas Health Science Center at San Antonio

San Antonio, Texas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06837181


Related Trials